Publications
5539 Results
- Journal / Conference
- Blood 104(11): #567
- Year
- 2004
- Research Committee(s)
- Leukemia
Acute myeloid leukemia (AML) with t(6;9)(p23;q34) defines a very poor risk leukemia subgroup with distinguishing clinicopathological features: a United States (US) cytogenetics Intergroup study of 62 AML and MDS cases.
- Journal / Conference
- Neuro-Oncology 6(4):350 (PA-03)
- Year
- 2004
- Research Committee(s)
- Brain
- Study Number(s)
- S0001
Prognostic value of epidermal growth factor receptor expression and small cell phenotype in patients with glioblastoma treated with induction chemotherapy, radiotherapy, 0-6 benzylguanine
- Journal / Conference
- Blood 104(12):3520-3526
- Year
- 2004
- Research Committee(s)
- Myeloma
- Study Number(s)
- S9628
Clinical efficacy of high dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup trial Southwest Oncology Group (SWOG) S9628
- Journal / Conference
- Blood 104(11): #1495
- Year
- 2004
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Genetic polymorphisms associated with clinical outcome in the Intergroup trial S9321, comparing high dose therapy with standard dose therapy for myelomaon, on behalf of ECOG, SWOG, CALGB, and the bank on a cure
- Journal / Conference
- Blood 104(11): #539
- Year
- 2004
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Comparable survival in newly diagnosed multiple myeloma (MM) after VAD induction with high dose therapy using melphalan 140mg/m2 + TBI 12 Gy (MEL + TBI) versus standard therapy with VBMCP and no benefit from interferon (IFN) maintenance: final clinical results of intergroup trial S9321 in the context of IFM 90 and MRC
- Journal / Conference
- ASCO Gastrointestinal Cancers Symposium #215
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- N9741
N9741: Oxaliplatin (Oxal) + CPT-11 or 5-fluorouracil (5FU)/leucovorin (LV) in advanced colorectal cancer (CRC): final efficacy data from an intergroup study
- Journal / Conference
- Blood 104(11): #394
- Year
- 2004
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Microgranular variant (M3V) of acute promyelocytic leukemia (APL) does not have a worse prognosis than classical APL in the atra era: a report of 153 patients treated on Intergroup 0129 and pethema LPA96 and LPA99.
- Journal / Conference
- Blood 104(11): #701
- Year
- 2004
- Research Committee(s)
- Lymphoma
LymphDx: a custom microarray for molecular diagnosis and prognosis in Non-Hodgkin lymphoma
- Journal / Conference
- SABCS, late acceptance:#37, http://www.abstracts2view.com/sabcs/sessionindex.php
- Year
- 2004
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814